3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
7
Completed
6
Active not recruiting
4
Terminated
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Breast
2
Head & Neck
1
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
2
Ovarian Neoplasms
1
Colorectal Neoplasms
1
Interventions
Trastuzumab
86
Cyclophosphamide
67
Capecitabine
67
Paclitaxel
63
Docetaxel
57
Fulvestrant
52
Letrozole
50
Carboplatin
42
pembrolizumab
40
Lapatinib
38
Doxorubicin
36
Anastrozole
32
Vinorelbine
31
Bevacizumab
31
exemestane
28
Tamoxifen
25
Gemcitabine
25
Albumin-Bound Paclitaxel
25
Radiotherapy
21
Taxes
18
atezolizumab
17
Everolimus
17
130-nm albumin-bound paclitaxel
17
pertuzumab
16
Epirubicin
16
palbociclib
15
eribulin
14
Magnetic Resonance Spectroscopy
14
Ado-Trastuzumab Emtansine
14
Goserelin
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Genetic Testing
×
Breast
×
Clear all
NCT02664389
2026-05-06
PANEL
University Hospital, Rouen
Phase NA
Terminated
289 enrolled
NCT02541188
2021-12-10
MediSein
University Hospital, Montpellier
Terminated
460 enrolled